1. Home
  2. OBAI vs GTBP Comparison

OBAI vs GTBP Comparison

Compare OBAI & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.36

Market Cap

15.2M

ML Signal

N/A

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

N/A

Current Price

$0.29

Market Cap

17.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OBAI
GTBP
Founded
2017
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
17.7M
IPO Year
2025
2016

Fundamental Metrics

Financial Performance
Metric
OBAI
GTBP
Price
$0.36
$0.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
629.2K
437.8K
Earning Date
05-27-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
40.53
3.75
EPS
N/A
N/A
Revenue
$9,972,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.42
N/A
52 Week Low
$0.36
$0.26
52 Week High
$19.95
$1.48

Technical Indicators

Market Signals
Indicator
OBAI
GTBP
Relative Strength Index (RSI) 34.24 35.03
Support Level N/A $0.27
Resistance Level $0.65 $0.47
Average True Range (ATR) 0.05 0.02
MACD -0.00 0.00
Stochastic Oscillator 10.83 0.75

Price Performance

Historical Comparison
OBAI
GTBP

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: